LFTD Partners (LIFD) 10-K 31 Mar 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 26, 2015	Jun. 30, 2014
Document and Entity Information:
Entity Registrant Name	ACQUIRED SALES CORP
Document Type	10-K
Document Period End Date	31-Dec-14
Amendment Flag	FALSE
Entity Central Index Key	1391135
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		2,269,648
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Public Float			$3,697,639

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current Assets
Cash and cash equivalents	$587,937	$427,294
Due from sale of subsidiary		1,000,000
Prepaid expenses	7,985
Total Current Assets	595,922	1,427,294
Note receivable	602,500
Interest receivable	35,926
Total Assets	1,234,348	1,427,294
Current Liabilities
Trade accounts payable	24,982	20,886
Obligation under stock repurchase		20,000
Total Current Liabilities	24,982	40,886
Shareholders' Equity (Deficit)
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 2,269,648 and 2,269,648 shares outstanding, respectively	2,270	2,270
Additional paid-in capital	13,554,524	8,410,295
Accumulated deficit	-12,347,428	-7,026,157
Total Shareholders' Equity (Deficit)	1,209,366	1,386,408
Total Liabilities and Shareholders' Equity (Deficit)	$1,234,348	$1,427,294

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Statement of Financial Position
Common Stock, par or stated value	$0.00	$0.00
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares outstanding	2,269,648	2,269,648
Preferred Stock, par or stated value	$0.00	$0.00
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, shares issued
Preferred Stock, shares outstanding

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Statement
Selling, General and Administrative Expense	($310,761)	($242,544)
Stock Compensation Expense	-5,144,229
Interest Income	35,926
Other Income	23,188
Loss from Extinguishment of Debt		-79,463
Interest Expense		-4,125
Loss from Continuing Operations	-5,395,876	-326,132
Gain on Disposal of Discontinued Operations	74,605	4,621,122
Income (Loss) from Discontinued Operations		178,916
Net Income (Loss)	($5,321,271)	$4,473,906
Basic and Diluted Earnings (Loss) per Share
Continuing Operations	($2.37)	($0.12)
Discontinued Operations	$0.03	$1.73
Basic and Diluted Earnings (Loss) per Share	($2.34)	$1.61

CONSOLIDATED_STATEMENTS_OF_SHA

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT (USD $)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Stockholders' Equity, beginning of period, Value at Dec. 31, 2012	$2,878	$8,187,846	($11,500,063)	($3,309,339)
Stockholders' Equity, beginning of period, Shares at Dec. 31, 2012	2,877,896
Stock issued in debt extinguishment, Value	83	271,758		271,841
Stock issued in debt extinguishment, Shares	82,548
Redemption of common stock, Value	-691	-49,309		-50,000
Redemption of common stock, Shares	-690,796
Net income (loss)			4,473,906	4,473,906
Stockholders' Equity, end of period, Value at Dec. 31, 2013	2,270	8,410,295	-7,026,157	1,386,408
Stockholders' Equity, end of period, Shares at Dec. 31, 2013	2,269,648
Net income (loss)			-5,321,271	-5,321,271
Stock issued to the Board of Directors for services previously rendered		5,144,229		5,144,229
Stockholders' Equity, end of period, Value at Dec. 31, 2014	$2,270	$13,554,524	($12,347,428)	$1,209,366
Stockholders' Equity, end of period, Shares at Dec. 31, 2014	2,269,648

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash Flows From Operating Activities
Net income (loss)	($5,321,271)	$4,473,906
Adjustments to reconcile income (loss) to net cash used in operating activities:
(Income)/loss from discontinued operations	-74,605	-4,800,038
Loss from extinguishment of debt		79,463
Stock compensation expense	5,144,229	0
Changes in operating assets and liabilities:
Prepaid expenses	-7,985
Accrued interest receivable	-35,926
Accounts payable	4,096	101,070
Accrued compensation		-150,000
Net cash used in operating activities of continuing operations	-291,462	-295,599
Net cash provided by (used in) operating activities of discontinued operations		-1,066,600
Net Cash Used in Operating Activities	-291,462	-1,362,199
Cash Flows From Investing Activities
Proceeds from sale of discontinued operations, net of cash sold	1,074,605	3,888,552
Note receivable	-602,500
Net cash used in investing activities of discontinued operations		-4,127
Net Cash Provided by Investing Activities	472,105	3,884,425
Cash Flow From Financing Activities
Proceeds from borrowing under related party note payable	300,000
Payments on notes payable		-650,070
Payments on notes payable - related parties	-300,000	-1,601,776
Payment of obligation under stock repurchase	-20,000	-30,000
Net Cash Provided by (Used in) Financing Activities	-20,000	-2,281,846
Net Increase in Cash	160,643	240,380
Cash and Cash Equivalents at Beginning of Year	427,294	186,914
Cash and Cash Equivalents at End of Year	587,937	427,294
Supplemental Cash Flow Information
Cash paid for interest		3,683
Cash paid for income taxes	834
Supplemental Disclosure of Noncash Investing and Financing Activities
Stock issued in extinguishment of debt to related party		$271,842

Note_1_Basis_of_Presentation_a

Note 1 - Basis of Presentation and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Notes
Note 1 - Basis of Presentation and Significant Accounting Policies	NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation – On February 13, 2012, Acquired Sales Corp (“Acquired Sales” or the “Company”) purchased 100% of the equity interests of Defense & Security Technology Group, Inc. (“DSTG”). On September 30, 2013, Acquired Sales sold 100% of the capital stock of DSTG to Minh Le, the previous owner of DSTG prior to its acquisition. DSTG’s results of operations have been included in the Company's operations through September 30, 2013 and have been reclassified as discontinued operations.
	On January 12, 2013, Acquired Sales entered into an agreement with Drumright Group, LLC (“Drumright”) that was closed on February 11, 2013, wherein Acquired Sales sold 100% of the capital stock of Cogility Software Corporation (“Cogility”) to Drumright. Cogility’s results of operations have been reclassified as discontinued operations.
	Principles of Consolidation – The accompanying consolidated financial statements include the accounts and operations of Acquired Sales for all periods presented, the accounts and discontinued operations of Cogility through February 11, 2013, and the accounts and discontinued operations of DSTG through September 30, 2013. Intercompany accounts and transactions have been eliminated on consolidation.
	Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Significant estimates include share-based compensation. Actual results and outcomes may differ from management’s estimates and assumptions.
	Income Taxes – Provisions for income taxes are based on taxes payable or refundable for the current year and deferred income taxes. Deferred income taxes are provided on differences between the tax bases of assets and liabilities and their reported amounts in the financial statements and on tax carry forwards. Deferred tax assets and liabilities are included in the financial statements at currently enacted income tax rates applicable to the period in which the deferred tax assets and liabilities are expected to be realized or settled. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. A valuation allowance is provided against deferred income tax assets when it is not more likely than not that the deferred income tax assets will be realized.
	Basic and Diluted Earnings (Loss) Per Common Share – Basic earnings (loss) per common share is determined by dividing earnings (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is calculated by dividing earnings (loss) by the weighted-average number of common shares and dilutive common share equivalents outstanding during the period. When dilutive, the incremental potential common shares issuable upon exercise of stock options and warrants are determined by the treasury stock method. The following table summarizes the calculations of basic and diluted earnings (loss) per common share for the years ended December 31, 2014 and 2013:
		For the Year Ended
		December 31,
		2014	2013
	Loss from continuing operations	($5,395,876)	($326,132)
	Income from discontinued operations	74,605	4,800,038
	Net income (loss)	($5,321,271)	$4,473,906
	Basic and Diluted Weighted
	Average Shares Outstanding	2,269,648	2,780,866
	Basic and Diluted Earnings (Loss) per Share
	Continuing Operations	($2.37)	($0.12)
	Discontinued Operations	0.03	1.73
	Net income (loss)	($2.34)	$1.61
	There were 6,198,774 stock options and warrants and 938,000 financing warrants outstanding during the year ended December 31, 2014 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive. There were 2,148,774 stock options and 938,000 financing warrants outstanding during the year ended December 31, 2013 that were excluded from the computation of earnings (loss) per share because their effects would have been anti-dilutive.
	Recent Accounting Pronouncements - In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The effective date will be the first quarter of fiscal year 2017 using one of two retrospective application methods. The Company has not determined the potential effects on the financial statements.
	In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-12, Compensation-Stock Compensation (Topic 718)-Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force). ASU No. 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition.  The effective date will be the first quarter of fiscal year 2016. The Company has not determined the potential effects on the financial statements.

Note_2_Risks_and_Uncertainties

Note 2 - Risks and Uncertainties	12 Months Ended
	Dec. 31, 2014
Notes
Note 2 - Risks and Uncertainties	NOTE 2 - RISKS AND UNCERTAINTIES
	Going Concern – The Company has a history of recurring losses, which have resulted in an accumulated deficit of $12,347,428 as of December 31, 2014. During the year ended December 31, 2014, the Company recognized a loss of $5,395,876 from continuing operations. The Company used net cash of $291,462 in operating activities of continuing operations. The sale of Cogility and DSTG eliminated the Company’s source of revenue. As a result, there is substantial doubt that the Company will be able to continue as a going concern. Bankruptcy of the Company at some point in the future is a possibility. The accompanying financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
	Management plans to sustain the Company as a going concern by taking the following actions: (1) acquiring and/or developing profitable businesses that will create positive income from operations; (2) acquiring valuable real estate in exchange for common stock and/or preferred stock; and/or (3) completing private placements of our common stock and/or preferred stock. Management believes that by taking these actions, the Company will be provided with sufficient future operations and cash flow to continue as a going concern. However, there can be no assurance that the Company will be successful in consummating such actions on acceptable terms, if at all. Moreover, any such actions can be expected to result in substantial dilution to the existing shareholders of the Company.

Note_3_Note_Receivable

Note 3 - Note Receivable	12 Months Ended
	Dec. 31, 2014
Notes
Note 3 - Note Receivable	NOTE 3 – NOTE RECEIVABLE
	The William Noyes Webster Foundation, Inc. (the "Foundation"), a non-profit Massachusetts corporation, has received a provisional registration from the Commonwealth of Massachusetts to own and operate a medical marijuana cultivation facility and dispensary in Barnstable County, Massachusetts. Jane W. Heatley ("Heatley") is the founder and a member of the board of directors of the Foundation.
	Teaming Agreement - On July 8, 2014, Acquired Sales Corp. ("AQSP") and Heatley agreed to use their respective best efforts, working exclusively together as a team, and not as a partnership or other entity, in order to consummate transactions, agreements, contracts and other arrangements pursuant to which AQSP will provide capital and expertise to the Foundation.
	Promissory Note - On July 14, 2014, the Foundation signed and delivered to AQSP a Secured Promissory Note (the "Note") which is in the stated loan amount of $1,500,000. The Note provides that the $1,500,000 loan may be advanced in one or more installments as the Foundation and AQSP may mutually agree upon. The Foundation and AQSP mutually agreed that the first installment of this loan would be $602,500. Pursuant to instructions from the Foundation, on July 14, 2014, AQSP paid $2,500 owed by the Foundation to one of its consultants, and AQSP advanced $600,000 directly to the Foundation. The amount and timing of subsequent loan installments under the Note, which could total $897,500, have not yet been mutually agreed upon between the Foundation and AQSP.
	The principal balance outstanding under the Note will bears interest at the rate of 12.5% per annum, compounded monthly. The Company accrued $35,926 in interest under the note for the period ended December 31, 2014. The first payment of accrued interest by the Foundation under the Note shall be made as soon after the Foundation commences operations of its medical marijuana cultivation facility and dispensary as the Foundation's cash flows shall reasonably permit, but in any event no later than one year after the Foundation commences operations. The principal of the Note shall be payable in eight consecutive equal quarterly installments, commencing on the last day of the calendar quarter in which the Foundation commences operations. Principal on the Note and related accrued interest will be considered past due if the aforementioned payments are not received by their due dates.
	The Company assessed the collectability of the Note based on the adequacy of the Foundation’s collateral and the Foundation’s capability of repaying the Note according to its terms. The Note is secured by, among other things, certain of the Foundation’s assets, as set out in a Security Agreement dated July 14, 2014. Based on this assessment, the Company has concluded that no allowance for loan losses was required as of December 31, 2014.

Note_4_Related_Party_Transacti

Note 4 - Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Notes
Note 4 - Related Party Transactions	NOTE 4 – RELATED PARTY TRANSACTIONS
	At December 31, 2012, the Company had recorded accrued compensation that included $570,979 in deferred payroll and vacation pay, and payroll taxes payable, $110,777 in employee reimbursements payable, and commissions payable to one current and one former employee in the aggregate amount of $198,967.  Under the terms of the sale of Cogility, all but $100,000 of the accrued compensation was paid on the date of acquisition. The Company determined that the additional accrued compensation of $100,000 was no longer necessary and reversed the accrual at December 31, 2013.
	On September 13, 2011, a key executive resigned his position and entered into a severance agreement with the Company.  On September 16, 2010, the Company had signed a letter agreeing to pay the former executive officer $47,000 in one-time commissions. Under the severance agreement the Company was also obligated to pay the former executive officer a one-time bonus of $35,000 and deferred compensation of $18,432. The liabilities were paid in full during the year ended December 31, 2013.

Note_5_Notes_Payable

Note 5 - Notes Payable	12 Months Ended
	Dec. 31, 2014
Notes
Note 5 - Notes Payable	NOTE 5 – NOTES PAYABLE
	Notes Payable to Related Parties – At December 31, 2012, the Company had notes payable to a significant shareholder, affiliated with an officer of the Company for $525,000. The notes were unsecured, non-interest bearing and due upon demand. The Company had entered into an agreement with the significant shareholder that, at such time as the Company was financially able to do so and at the reasonable discretion of the chief executive officer of the Company, the notes payable held by the significant shareholder would be extinguished in full by the payment of $262,500 in cash and the issuance of 82,548 shares common stock. Based on the fair value of the Company’s common stock on the date of the agreement of $3.18 per share, the significant shareholder received a contingent beneficial conversion feature in connection with the agreement. The liability was settled with the payment of $262,500 and the issuance of 82,548 shares of common stock during the year ended December 31, 2013. The Company recognized a loss from extinguishment of debt of $10,980 during the year ended December 31, 2013.
	At December 31, 2012, the Company had $375,000 of notes payable to related parties that were secured by all the assets of the Company, bore interest at 3% per annum and were due December 31, 2014. The notes were issued with warrants to purchase common stock that resulted in the notes payable being carried at a discount to their face value. At February 11, 2013, the carrying amount of the notes payable was $344,601, net of $30,399 of unamortized discount. The liability was paid in full during the year ended December 31, 2013. The Company recognized a loss of $30,399 on early extinguishment of debt relating to unamortized discount.
	On January 30, 2012, an officer advanced the Company $75,000 for short-term working capital needs. The loan was without interest, unsecured and due upon demand. On April 1, 2012, the terms of the loan were renegotiated such that the loan bore interest at 6% per annum, payable quarterly, and was due upon demand. The liability was paid in full during the year ended December 31, 2013.
	In connection with the acquisition of DSTG on February 13, 2012, the Company assumed an $86,000 distribution payable to the former DSTG shareholder. The liability was without interest, due upon demand and unsecured. On July 25, 2012, the terms of the loan were renegotiated such that the loan bore interest at 6% per annum, payable quarterly, and was due upon demand. The liability was paid in full during the year ended December 31, 2013.
	During 2012, the Company borrowed $325,000 from a director of the Company from an entity related to an officer of the Company. All of the related notes payable bear interest at 6% per annum, payable quarterly, and were due upon demand. The notes were paid in full during the year ended December 31, 2013.
	On March 31, 2012, a significant shareholder advanced the Company $60,000 for short-term working capital needs.  The loan was without interest, unsecured and due upon demand.  The note payable was paid in full on April 13, 2012.
	On June 4, 2012, the Company borrowed an additional $100,000 from an officer of the Company. The related note payable bore interest at 6% per annum, payable quarterly, and was due upon demand. The liability was paid in full during the year ended December 31, 2013.
	During 2012, the Company borrowed $230,000 from an officer of the Company and from an entity related to an officer of the Company. All of the related notes payable bore interest at 6% per annum, payable quarterly, and were due upon demand. The liability was paid in full during the year ended December 31, 2013.
	During 2012, the Company borrowed $140,000 from an entity related to an officer of the Company, from a director of the Company and from an officer of the Company. All of the related notes payable bore interest at 6% per annum, payable quarterly, and were due upon demand. The notes payable were paid in full during the year ended December 31, 2013.
	At March 31, 2013, an officer of the Company had advanced the Company a total of $32,500 for short-term working capital needs. The loan was without interest, unsecured and due upon demand. The advance was paid in full during the year ended December 31, 2013. Interest paid to related parties during the year ended December 31, 2013 was $4,126.
	At December 31, 2012, notes payable to a lending company totaled $130,070, were unsecured, non-interest bearing and due on demand. The liability was paid in full during the year ended December 31, 2013.
	At December 31, 2012, The Company had $520,000 of notes payable to third parties that were secured by all the assets of the Company, bore interest at 3% per annum and were due December 31, 2014. The notes were issued with warrants to purchase common stock that resulted in the notes payable being carried at a discount to their face value. At December 31, 2012, the carrying amount of the notes was $480,480, net of $39,520 of unamortized discount. The liability was paid in full during the year ended December 31, 2013. The Company recognized a loss of $39,520 on early extinguishment of debt relating to the unamortized discount.
	On July 14, 2014, AQSP borrowed $300,000 from the Roberti Jacobs Family Trust (the "Trust"). The Trust is an affiliate of Gerard M. Jacobs, AQSP's chief executive officer.  The loan was repaid in full on August 5, 2014.

Note_6_Shareholders_Equity

Note 6 - Shareholders' Equity	12 Months Ended
	Dec. 31, 2014
Notes
Note 6 - Shareholders' Equity	NOTE 6 – SHAREHOLDERS’ EQUITY
	Share-Based Compensation – The Company has granted its chief executive officer and directors the rights to purchase warrants to purchase common stock as compensation for their services. Share-based compensation expense recognized during the years ended December 31, 2014 and 2013 was $5,144,229 and $0, respectively. No income tax benefit was recognized with respect to the share-based compensation. In prior years, the Company has also granted stock options and warrants as compensation to management, to the board of directors, and to a consultant.
	On November 28, 2014, our chief executive officer and directors were issued rights to purchase warrants, which do not require shareholder approval, to purchase an aggregate of 1,350,000 shares of common stock of the Company at $0.01 per share and rights to purchase warrants to purchase an aggregate of 1,350,000 shares of common stock at $1.85 per share, which rights to purchase warrants do not require shareholder approval. The $0.01 warrants became exercisable once the Company’s common stock closed at not less than $3.50 per share on at least ten consecutive trading days. This condition was met in December 2014. The $1.85 warrants contained this condition which has been met, but 1,250,000 of the $1.85 warrants also are conditioned upon the acquisition by the Company of at least one of certain real estate properties owned by entities controlled by our director Vincent J. Mesolella. When exercisable, the warrants are exercisable through December 31, 2024. The grant-date fair value of these warrants was $5,144,229, or a weighted-average fair value of $1.91 per share, determined by the Black-Scholes option pricing model using the following weighted-average assumptions: expected future stock volatility of 147%; risk-free interest rate of 1.49%; dividend yield of 0% and an expected term of 5.0 years. The expected future stock volatility was based on the combined volatility of Acquired Sales’ Corp.’s stock and two peer companies’ stock volatilities. The risk-free interest rate was based on the U.S. Federal treasury rate for instruments due over the expected term of the warrants. The expected term of each warrant was based on the midpoint between the date the warrant vests and the contractual term of the warrant.
	On November 28, 2014, our chief executive officer and directors were also issued rights to purchase warrants, which do not require shareholder approval, to purchase 1,350,000 shares of common stock of the Company at the same price per share of Acquired Sales’ stock paid by the investor(s) in the capital raise of at least $15,000,000 by May 31, 2015 to fund the cash portion of the PPV merger consideration (the “Capital Raise Price Per Share”), with the exercise of 1,250,000 of these warrants being conditioned upon the acquisition by the Company of four real estate properties owned by entities controlled by our director Vincent J. Mesolella.
	The fair value of the warrants was estimated by a valuation firm, on the date of grant, using a Monte Carlo Simulation model. Using this model, we assumed that the performance conditions would be achieved. If such conditions were not met, no compensation cost would be recognized and any recognized compensation cost would be reversed.
	The weighted-average grant-date fair value of the warrants was $1.88 per share, for a total value of $2,536,472, based on the following weighted-average assumptions: an expected future stock volatility of 147%, which was the combined volatility of Acquired Sales’ stock and two peer companies’ stock volatilities; risk-free interest rate of 1.50% and a dividend yield of 0%. The expected term of 5.0 years was determined by the simulation. The risk-free interest rate was based on the US Treasury Constant Maturity Yield over the expected term of the warrants. The Company terminated its letter of intent to acquire PPV on March 11, 2015, and as such terminated its efforts to raise the capital necessary to acquire PPV. Consequently, it is not probable that these warrants will vest, and no compensation expense related to these warrants has been recognized to date.
	The following is a summary of share-based compensation, stock option and warrant activity as of December 31, 2014 and changes during the year then ended:
				Weighted-Average
			Weighted-Average	Remaining Contractual	Aggregate
					Intrinsic
		Shares	Exercise Price (a)	Term (Years)	Value
	Outstanding, December 31, 2013	2,148,774	$2.35
	Granted in 2014	4,050,000	$0.93
	Outstanding, December 31, 2014	6,198,774	$1.56	8.14	$3,138,875
	Exercisable, December 31, 2014	3,598,774	$1.46	6.8	$2,951,375
	Notes:
	(a) The Weighted-Average Exercise Price column excludes those warrants that have an exercise price for the common stock priced at the Capital Raise Price Per Share.
	Financing Warrants – Through December 31, 2012, the Company issued 938,000 warrants in connection with the issuance of notes payable primarily to related parties. The warrants were outstanding at December 31, 2013 and 2014. At December 31, 2014, the financing warrants had a weighted-average exercise price of $2.32 per share, a weighted-average remaining contractual term of 1.85 years and no aggregate intrinsic value.
	Common Stock – On October 17, 2013, the Company entered into a settlement agreement with Matthew Ghourdjian and the Deborah Sue Ghourdjian Separate Property Trust, whereby Mr. Ghourdjian and the Trust sold to the Company 690,796 shares of common stock for $30,000 cash plus an obligation to pay an additional $20,000 in February 2014, or approximately $0.07 per share. Mr. Ghourdjian resigned from the Company as an employee, director and officer. Mr. Ghourdjian and the Trust, and the Company entered into mutual releases of all claims against one another.  The obligation was paid in February 2014.
	Also on October 17, 2013, Mr. Roger Greene entered into a settlement agreement with the Company whereby Mr. Greene forfeited his options to purchase 25,000 shares of common stock of the Company at $0.001 per share. In addition, Mr. Greene and the Company signed mutual releases of any and all claims against one another. Mr. Greene resigned as a director of the Company on that date.

Note_7_Income_Taxes

Note 7 - Income Taxes	12 Months Ended
	Dec. 31, 2014
Notes
Note 7 - Income Taxes	NOTE 7 – INCOME TAXES
	During the years ended December 31, 2014 and 2013, the Company did not incur any current tax on its continuing operations and there was no deferred tax provision or benefit from continuing operations. At December 31, 2014, the Company has U.S. Federal net operating loss carry forwards of $487,878 that will expire in 2030 through 2034 if not used by those dates.
	As of December 31, 2014, the Company had no unrecognized tax benefits that, if recognized, would affect the Company’s effective income tax rate over the next 12 months. The Company currently believes that all significant filing positions are highly certain and that all of its significant income tax filing positions and deductions would be sustained upon audit. Therefore, the Company has no significant reserves for uncertain tax positions and no adjustments to such reserves were required by generally accepted accounting principles. The Company’s policy is to recognize accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes. The Company’s tax returns are subject to examination for the years ended December 31, 2010 through 2014. A reconciliation of the amount of tax benefit computed using the U.S. federal statutory income tax rate to the provision for income taxes on continuing operations is as follows:
		For the Years Ended
		December 31,
		2014	2013
	Tax expenses (benefit) at statutory rate (34%)	($1,834,598)	($114,146)
	State tax benefit, net of federal benefit	-178,064	870,307
	Non-deductible expenses	4,074	940
	Revision of prior years' deferred tax assets	-86,347	-
	Change in estimated future income tax rates	7,254	-
	Change in valuation allowance	2,087,681	127,923
	Net Deferred Income Tax Asset	$-	$-
	The tax effects of temporary differences and carry forwards that gave rise to the net deferred income tax asset as of December 31, 2014 and 2013 were as follows:
		December 31,
		2014	2013
	Operating loss carry forwards	$181,979	$126,179
	Stock-based compensation	2,874,359	870,307
	Less: Valuation allowance	-3,056,338	-996,486
	Net Deferred Income Tax Asset	$-	$-
	The deferred tax asset valuation allowance increased by $2,059,852 and decreased by $2,819,473 during the years ended December 31, 2014 and 2013, respectively.

Note_8_Contingent_Contractual_

Note 8 - Contingent Contractual Obligations and Commercial Commitments	12 Months Ended
	Dec. 31, 2014
Notes
Note 8 - Contingent Contractual Obligations and Commercial Commitments	NOTE 8 – CONTINGENT CONTRACTUAL OBLIGATIONS AND COMMERCIAL COMMITMENTS
	As discussed in Note 3, the Company has commitments under agreements with the William Noyes Webster Foundation, Inc.
	Medical marijuana on Cape Cod:
	AQSP has agreed to pay a lump sum finder's fee to Parare Partners Inc. in the event that all of the following conditions occur: (1) AQSP makes certain loans to the William Noyes Webster Foundation, Inc. (the "Foundation") which was found by Parare Partners Inc., (2) the Foundation constructs and brings into operation its planned medical marijuana cultivation facility and dispensary in Massachusetts, (3) AQSP directly or via subsidiaries enters into certain consulting agreements with the Foundation, and (4) all necessary approvals are obtained. If all of such conditions occur, then the finder's fee will be calculated as follows: (i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000.
	Medical marijuana in California and Oregon:
	AQSP has agreed to pay a lump sum finder’s fee to Parare Partners Inc. in the event that all of the following conditions occur: (1) AQSP makes certain loans to a company found by Parare Partners Inc. (the "Cal/Ore Company") that wants to purchase certain medical marijuana facilities in  California and Oregon (the "Cal/Ore Facilities"), (2) the Cal/Ore Company purchases the Cal/Ore Facilities, (3) AQSP directly or via subsidiaries enters into purchase agreements with the Cal/Ore Company regarding the Cal/Ore Facilities, and (4) all necessary approvals are obtained. If all of such conditions occur, then the finder's fee will be calculated as follows: (i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000.

Note_9_Sale_of_Subsidiaries_an

Note 9 - Sale of Subsidiaries and Discontinued Operations	12 Months Ended
	Dec. 31, 2014
Notes
Note 9 - Sale of Subsidiaries and Discontinued Operations	NOTE 9 – SALE OF SUBSIDIARIES AND DISCONTINUED OPERATIONS
	Cogility Software Corporation – On January 12, 2013, Acquired Sales entered into an agreement with Drumright Group, LLC (“Drumright”) that was closed on February 11, 2013, wherein Acquired Sales sold 100% of the capital stock of its subsidiary, Cogility Software Corporation (“Cogility”) to Drumright in exchange for $3,975,000 in cash and a $3,000,000 receivable. The $3,000,000 was originally receivable as follows: $1,500,000 on August 11, 2013, less an estimated $32,258 in connection with a certain military contract delay, and $1,500,000 on February 11, 2014.
	In addition, Acquired Sales was required to hold $300,000 in an escrow account for potential subsequent claims. Acquired Sales was responsible for all costs and expenses and retained all accounts receivable relating to work performed by Cogility on revenue contracts through January 31, 2013, with those costs, expenses and revenue transitioning to Drumright thereafter. During the twelve months ended December 31, 2014, Cogility collected on an account receivable retained by Acquired Sales that had been deemed uncollectible in the amount of $74,605. The amount is recorded as an adjustment to the gain on sale. Acquired Sales retained a contract to create “legal analytics” software. The carrying value of Cogility’s net liabilities, excluding accounts receivable, was $32,899.
	Under the terms of the agreement, Acquired Sales was required to transfer Cogility to Drumright without any liabilities. To accomplish this requirement, the $3,975,000 down payment was placed into an escrow account and to the extent necessary was used to pay Cogility’s liabilities, including liabilities that were secured by Cogility’s assets or its capital stock.
	The Company agreed to indemnify Drumright for losses caused by breach of the Company’s representations and warranties. In March 2013, Drumright notified the Company of the existence of a second amendment to a license agreement between Cogility and one of its customers that was effective April 2007. On July 16, 2013, the parties entered into a Compromise and Release agreement whereby the parties agreed to reduce the purchase price by $2,000,000 by reducing the $3,000,000 receivable to $1,000,000 due and paid on February 11, 2014. As a result of the Compromise and Release agreement, the Company recognized a reduced gain on disposal of discontinued operations relating to the sale of Cogility of $4,726,068.
	On September 30, 2013, Acquired Sales sold 100% of the common stock of Defense & Security Technology Group, Inc. (“DSTG”) back to its previous shareholder for $1. The Company recognized a loss on sale of $104,946 during the year ended December 31, 2013.
	Revenue Recognition – While held by the Company, Cogility and DSTG entered into contractual arrangements with end-users of its products to sell software licenses, hardware, consulting services and maintenance services, either separately or in various combinations thereof. For each arrangement, revenue was recognized when persuasive evidence of an arrangement existed, the fees to be paid by the customer were fixed or determinable, collection of the fees was probable, and delivery of the product or services had occurred. When Cogility or DSTG was the primary obligor or bore the risk of loss, revenue and costs were recorded on a gross basis and when they received fixed transactional fees, revenue was recorded under the net method based on the net amount retained.
	In contractual arrangements where services were essential to the functionality of the software or hardware, or payment of the license fees were dependent upon the performance of the related services, revenue for the software license, hardware and consulting fees were recognized on the completed-contract method when the contract was substantially completed and all related deliverables had been provided to and accepted by the customer. This method was used because management of Cogility and DSTG were unable to accurately estimate total cost of individual contracts until the contracts were substantially completed. Provisions for estimated losses on uncompleted contracts were made in the period in which such losses were determined. Claims for additional compensation were recognized during the period such claims were resolved and collected.
	Costs of software, hardware and costs incurred in performing contract services were deferred until the related revenue was recognized. Contract costs included all purchased software and hardware, subcontract and labor costs and those indirect costs related to contract performance, such as indirect labor, supplies, equipment, and travel costs as well as depreciation on equipment used in performance of the contractual arrangements.
	Consulting Services: Consulting services were comprised of consulting, implementation, software installation, data conversion, building interfaces to allow the software to operate in integrated environments, training and applications. Consulting services were sold on a fixed-fee and a time-and-materials basis, with payment normally due upon achievement of specific milestones. Consulting services revenue was recognized under the completed-contract method as described above.

Note_1_Basis_of_Presentation_a1

Note 1 - Basis of Presentation and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Policies
Principles of Consolidation	Principles of Consolidation – The accompanying consolidated financial statements include the accounts and operations of Acquired Sales for all periods presented, the accounts and discontinued operations of Cogility through February 11, 2013, and the accounts and discontinued operations of DSTG through September 30, 2013. Intercompany accounts and transactions have been eliminated on consolidation.
Use of Estimates	Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. Significant estimates include share-based compensation. Actual results and outcomes may differ from management’s estimates and assumptions.
Income Taxes	Income Taxes – Provisions for income taxes are based on taxes payable or refundable for the current year and deferred income taxes. Deferred income taxes are provided on differences between the tax bases of assets and liabilities and their reported amounts in the financial statements and on tax carry forwards. Deferred tax assets and liabilities are included in the financial statements at currently enacted income tax rates applicable to the period in which the deferred tax assets and liabilities are expected to be realized or settled. As changes in tax laws or rates are enacted, deferred tax assets and liabilities are adjusted through the provision for income taxes. A valuation allowance is provided against deferred income tax assets when it is not more likely than not that the deferred income tax assets will be realized.
Basic and Diluted Earnings (Loss) Per Common Share	Basic and Diluted Earnings (Loss) Per Common Share – Basic earnings (loss) per common share is determined by dividing earnings (loss) by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per common share is calculated by dividing earnings (loss) by the weighted-average number of common shares and dilutive common share equivalents outstanding during the period. When dilutive, the incremental potential common shares issuable upon exercise of stock options and warrants are determined by the treasury stock method. The following table summarizes the calculations of basic and diluted earnings (loss) per common share for the years ended December 31, 2014 and 2013:
		For the Year Ended
		December 31,
		2014	2013
	Loss from continuing operations	($5,395,876)	($326,132)
	Income from discontinued operations	74,605	4,800,038
	Net income (loss)	($5,321,271)	$4,473,906
	Basic and Diluted Weighted
	Average Shares Outstanding	2,269,648	2,780,866
	Basic and Diluted Earnings (Loss) per Share
	Continuing Operations	($2.37)	($0.12)
	Discontinued Operations	0.03	1.73
	Net income (loss)	($2.34)	$1.61
	There were 6,198,774 stock options and warrants and 938,000 financing warrants outstanding during the year ended December 31, 2014 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive. There were 2,148,774 stock options and 938,000 financing warrants outstanding during the year ended December 31, 2013 that were excluded from the computation of earnings (loss) per share because their effects would have been anti-dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements - In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. This ASU is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The effective date will be the first quarter of fiscal year 2017 using one of two retrospective application methods. The Company has not determined the potential effects on the financial statements.
	In June 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-12, Compensation-Stock Compensation (Topic 718)-Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force). ASU No. 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition.  The effective date will be the first quarter of fiscal year 2016. The Company has not determined the potential effects on the financial statements.

Note_1_Basis_of_Presentation_a2

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted
		For the Year Ended
		December 31,
		2014	2013
	Loss from continuing operations	($5,395,876)	($326,132)
	Income from discontinued operations	74,605	4,800,038
	Net income (loss)	($5,321,271)	$4,473,906
	Basic and Diluted Weighted
	Average Shares Outstanding	2,269,648	2,780,866
	Basic and Diluted Earnings (Loss) per Share
	Continuing Operations	($2.37)	($0.12)
	Discontinued Operations	0.03	1.73
	Net income (loss)	($2.34)	$1.61

Note_6_Shareholders_Equity_Sch

Note 6 - Shareholders' Equity: Schedule of Share-based Compensation, Stock Options and Warrant Activity (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Share-based Compensation, Stock Options and Warrant Activity	The following is a summary of share-based compensation, stock option and warrant activity as of December 31, 2014 and changes during the year then ended:
				Weighted-Average
			Weighted-Average	Remaining Contractual	Aggregate
					Intrinsic
		Shares	Exercise Price (a)	Term (Years)	Value
	Outstanding, December 31, 2013	2,148,774	$2.35
	Granted in 2014	4,050,000	$0.93
	Outstanding, December 31, 2014	6,198,774	$1.56	8.14	$3,138,875
	Exercisable, December 31, 2014	3,598,774	$1.46	6.8	$2,951,375
	Notes:
	(a) The Weighted-Average Exercise Price column excludes those warrants that have an exercise price for the common stock priced at the Capital Raise Price Per Share.

Note_7_Income_Taxes_Schedule_o

Note 7 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Effective Income Tax Rate Reconciliation
		For the Years Ended
		December 31,
		2014	2013
	Tax expenses (benefit) at statutory rate (34%)	($1,834,598)	($114,146)
	State tax benefit, net of federal benefit	-178,064	870,307
	Non-deductible expenses	4,074	940
	Revision of prior years' deferred tax assets	-86,347	-
	Change in estimated future income tax rates	7,254	-
	Change in valuation allowance	2,087,681	127,923
	Net Deferred Income Tax Asset	$-	$-

Note_7_Income_Taxes_Schedule_o1

Note 7 - Income Taxes: Schedule of Deferred Tax Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Tables/Schedules
Schedule of Deferred Tax Assets	The tax effects of temporary differences and carry forwards that gave rise to the net deferred income tax asset as of December 31, 2014 and 2013 were as follows:
		December 31,
		2014	2013
	Operating loss carry forwards	$181,979	$126,179
	Stock-based compensation	2,874,359	870,307
	Less: Valuation allowance	-3,056,338	-996,486
	Net Deferred Income Tax Asset	$-	$-

Note_1_Basis_of_Presentation_a3

Note 1 - Basis of Presentation and Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2012	Sep. 30, 2013	Jan. 12, 2013
Defense Securities Technology Group
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions	100.00%
Defense & Security Technology Group, Inc
Stock Sold to Acquirer, percent		100.00%
Drumright Group LLC purchase of Cogility
Stock Sold to Acquirer, percent			100.00%

Note_1_Basis_of_Presentation_a4

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Details
Loss from Contining Operations	($5,395,876)	($326,132)
Income from Discontinued Operations	74,605	4,800,038
Net income (loss)	($5,321,271)	$4,473,906
Basic and Diluted Weighted
Average Shares Outstanding	2,269,648	2,780,866
Basic and Diluted Earnings (Loss) per Share
Continuing Operations	($2.37)	($0.12)
Discontinued Operations	$0.03	$1.73
Net income (loss)	($2.34)	$1.61

Note_1_Basis_of_Presentation_a5

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Equity Option
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	6,198,774	2,148,774
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	938,000	938,000

Note_2_Risks_and_Uncertainties1

Note 2 - Risks and Uncertainties (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Details
Accumulated deficit	($12,347,428)	($7,026,157)
Loss from Contining Operations	-5,395,876	-326,132
Net cash used in operating activities of continuing operations	($291,462)	($295,599)

Note_3_Note_Receivable_Details

Note 3 - Note Receivable (Details) (USD $)	1 Months Ended
	Jul. 31, 2014	Dec. 31, 2014
Accrued Interest Receivable		$35,926
Secured Promissory Note | William Noyes Webster Foundation Inc
Debt Instrument, Face Amount		1,500,000
Note Receivable		602,500
Advances	600,000
Debt Instrument, Interest Rate, Stated Percentage		12.50%
Secured Promissory Note | William Noyes Webster Foundation Inc | Payment To Consultant
Advances	2,500
Secured Promissory Note | William Noyes Webster Foundation Inc | Unfunded Portion of Note
Debt Instrument, Face Amount		$897,500

Note_4_Related_Party_Transacti1

Note 4 - Related Party Transactions (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jun. 13, 2011	Sep. 16, 2010
Employee-related Liabilities, Current		$100,000	$570,979
Due to Employees, Current	110,777
Accrued Sales Commission, Current	198,967
Executive Officer
Officer Commission Due Upon Closing of Private Placement					47,000
Officer Commission After Severance Due Upon Closing of Private Placement				35,000
Officer Deferred Compensation After Severance Due Upon Closing of Private Placement				$18,432

Note_5_Notes_Payable_Details

Note 5 - Notes Payable (Details) (USD $)

12 Months Ended

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Feb. 11, 2013

Jul. 25, 2012

Feb. 13, 2012

Mar. 31, 2012

Mar. 31, 2013

Jun. 30, 2012

Jun. 04, 2012

Jan. 30, 2012

Jul. 14, 2014

Payments on notes payable - related parties

$300,000

$1,601,776

Loss from extinguishment of debt

79,463

Interest Expense, Related Party

4,126

Notes Payable to Related Parties 1

Notes Payable, Related Parties

375,000

Loss from extinguishment of debt

30,399

Debt Instrument, Interest Rate, Stated Percentage

3.00%

Long-term Debt, Net of Unamortized Discount

344,601

Debt Instrument, Unamortized Discount

30,399

Unsecured Debt 1

Debt Instrument, Interest Rate, Stated Percentage

6.00%

Debt Instrument, Face Amount

86,000

Notes Payable to Related Parties 2

Debt Instrument, Interest Rate, Stated Percentage

6.00%

Debt Instrument, Face Amount

325,000

Unsecured Debt 2

Due from Officers or Stockholders, Current

60,000

Notes Payable to Related Parties 3

Debt Instrument, Interest Rate, Stated Percentage

6.00%

Debt Instrument, Face Amount

230,000

Notes Payable to Related Parties 4

Debt Instrument, Interest Rate, Stated Percentage

6.00%

Debt Instrument, Face Amount

140,000

Unsecured Debt 3

Debt Instrument, Face Amount

130,070

Secured Third Party Notes

Loss from extinguishment of debt

39,520

Debt Instrument, Interest Rate, Stated Percentage

3.00%

Long-term Debt, Net of Unamortized Discount

480,480

Debt Instrument, Unamortized Discount

39,520

Debt Instrument, Face Amount

520,000

Immediate Family Member of Management or Principal Owner

Notes Payable, Related Parties

525,000

Payments on notes payable - related parties

262,500

262,500

Debt Instrument, Convertible, Conversion Price

$3.18

Loss from extinguishment of debt

10,980

Immediate Family Member of Management or Principal Owner | Common Stock

Debt Conversion, Converted Instrument, Shares Issued

82,548

82,548

Officer

Debt Instrument, Interest Rate, Stated Percentage

6.00%

6.00%

Notes Payable, Related Parties, Current

32,500

100,000

75,000

Roberti Jacobs Family Trust

Debt Instrument, Face Amount

$300,000

Note_6_Shareholders_Equity_Det

Note 6 - Shareholders' Equity (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Feb. 28, 2014	Oct. 17, 2013
Stock compensation expense	$5,144,229	$0
Class of Warrant, Outstanding	938,000	938,000
Class of Warrant, Exercise Price of Warrants	$2.32
Minimum Capital Raise needed to fund PPV Merger	15,000,000
Warrants to Be Issued Upon Acquisition of Real Estate	1,250,000
Payment to Mr. Ghourdjian for Purchase of Common Stock	20,000	30,000
Payment to Mr. Ghourdjian for Purchase of Common Stock	$20,000	$30,000
Matthew Ghourdjian
Share Price			$0.07
Roger Greene
Share Price				$0.00
Options, Forfeited in Period	25,000
Common Stock
Redemption of common stock, Shares		-690,796
Warrant | Notes Payable to Related Parties
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	1 year 10 months 6 days
Warrant 1
Class of Warrant, Outstanding	1,350,000
Class of Warrant, Exercise Price of Warrants	$0.01
Warrant 2
Class of Warrant, Outstanding	1,350,000
Class of Warrant, Exercise Price of Warrants	$1.85
Warrants 1 and 2
Terms of Award	The $0.01 warrants became exercisable once the Company’s common stock closed at not less than $3.50 per share on at least ten consecutive trading days. This condition was met in December 2014. The $1.85 warrants contained this condition which has been met, but 1,250,000 of the $1.85 warrants also are conditioned upon the acquisition by the Company of at least one of certain real estate properties owned by entities controlled by our director Vincent J. Mesolella. When exercisable, the warrants are exercisable through December 31, 2024.
Grants in Period, Weighted Average Grant Date Fair Value	$1.91
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Method Used	Black-Scholes option pricing model
Expected Future Stock Volatility	147.00%
Risk Free Interest Rate	1.49%
Dividend Yield	0.00%
Expected Term	5 years
Warrants 3
Class of Warrant, Outstanding	1,350,000
Grants in Period, Weighted Average Grant Date Fair Value	$1.88
Expected Future Stock Volatility	147.00%
Risk Free Interest Rate	1.50%
Dividend Yield	0.00%
Expected Term	5 years

Note_6_Shareholders_Equity_Sch1

Note 6 - Shareholders' Equity: Schedule of Share-based Compensation, Stock Options and Warrant Activity (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
Details
Options, Outstanding, Beginning Balance	2,148,774
Options, Outstanding, Weighted Average Exercise Price, Beginning Balance	$2.35
Granted in 2014	4,050,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$0.93
Options, Outstanding, Ending Balance	6,198,774
Options, Outstanding, Weighted Average Exercise Price, Ending Balance	$1.56
Options, Outstanding, Weighted Average Remaining Term	8 years 1 month 20 days
Options, Outstanding, Intrinsic Value	$3,138,875
Options, Exercisable	3,598,774
Options, Exercisable, Weighted Average Exercise Price	$1.46
Options, Exercisable, Weighted Average Remaining Term	6 years 9 months 18 days
Options, Exercisable, Intrinsic Value	$2,951,375

Note_7_Income_Taxes_Details

Note 7 - Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Net Operating Loss Carryforwards	$487,878
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$2,059,852	($2,819,473)
Minimum
Operating Loss Carryforwards, Expiration Date	31-Dec-30
Maximum
Operating Loss Carryforwards, Expiration Date	31-Dec-34

Note_7_Income_Taxes_Schedule_o2

Note 7 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Details
Tax expenses (benefit) at statutory rate (34%)	($1,834,598)	($114,146)
State tax benefit, net of federal benefit	-178,064	870,307
Non-deductible expenses	4,074	940
Revision of prior years' deferred tax assets	-86,347	0
Change in estimated future income tax rates	7,254	0
Change in valuation allowance	2,087,681	127,923
Net Deferred Income Tax Asset	$0	$0

Note_7_Income_Taxes_Schedule_o3

Note 7 - Income Taxes: Schedule of Deferred Tax Assets (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Details
Operating loss carry forwards	$181,979	$126,179
Stock-based compensation	2,874,359	870,307
Less: Valuation allowance	-3,056,338	-996,486
Net Deferred Income Tax Asset	$0	$0

Note_8_Contingent_Contractual_1

Note 8 - Contingent Contractual Obligations and Commercial Commitments (Details) (Parere Partners Inc.)	12 Months Ended
	Dec. 31, 2014
Medical marijuana on Cape Cod
Commitments Under Agreements with the William Noyes Webster Foundation, Inc.	(i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000.
Medical marijuana in California and Oregon
Commitments Under Agreements with the William Noyes Webster Foundation, Inc.	(i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000.

Note_9_Sale_of_Subsidiaries_an1

Note 9 - Sale of Subsidiaries and Discontinued Operations (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Jul. 16, 2013	Feb. 11, 2013	Jan. 12, 2013	Sep. 30, 2013
Proceeds from sale of discontinued operations, net of cash sold	$1,074,605	$3,888,552
Drumright Group LLC purchase of Cogility
Stock Sold to Acquirer, percent					100.00%
Proceeds from sale of discontinued operations, net of cash sold		3,975,000
Business Divestiture, Deferred Purchase Amount Receivable				3,000,000
Business Divestiture, Deferred Purchase Amount Receivable, Due in 6 Months				1,500,000
Business Divestiture, Deferred Purchase Amount Receivable, Deduction Allowance			2,000,000	32,258
Business Divestiture, Deferred Purchase Amount Receivable, Due in 1 Year				1,500,000
Business Divestiture, Escrow Collateral				300,000
Sale of Subsidiary, Down Payment Terms		Under the terms of the agreement, Acquired Sales was required to transfer Cogility to Drumright without any liabilities. To accomplish this requirement, the $3,975,000 down payment was placed into an escrow account and to the extent necessary was used to pay Cogility’s liabilities, including liabilities that were secured by Cogility’s assets or its capital stock.
Stock Sold to Acquirer, percent					100.00%
Cogility Software
Proceeds from Collection of Accounts Receivable that had been Deemed Uncollectible	74,605
Net Liabilities					32,899
Gain (Loss) on Disposition of Business	4,726,068
Defense & Security Technology Group, Inc
Stock Sold to Acquirer, percent						100.00%
Proceeds from sale of discontinued operations, net of cash sold		1
Stock Sold to Acquirer, percent						100.00%
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax		$104,946